ApicHope Pharmaceutical Co., Ltd (300723.SZ)
CNY 39.3
(-6.36%)
CNY 39.3
(-6.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 458.05 Million | 475.53 Million | 438.1 Million | 275.22 Million | 280.64 Million | 238.59 Million |
| Net Income | 151.79 Million | 262.09 Million | 293.41 Million | 223.63 Million | 142.52 Million | 207.68 Million |
| Depreciation & Amortization | 182.2 Million | 97.45 Million | 73.46 Million | 40.67 Million | 37.96 Million | 36.05 Million |
| Deferred income taxes | -16.09 Million | -20.24 Million | -636.97 Thousand | 3.9 Million | -5.61 Million | -3.09 Million |
| Stock-based compensation | -10.78 Million | 15.8 Million | 13.79 Million | -8.03 Million | 4.97 Million | 7.16 Million |
| Change in working capital | 47.83 Million | 24.52 Million | 45.63 Million | 16.65 Million | 49.97 Million | -18.01 Million |
| Other non-cash items | 57.96 Million | 91.46 Million | 25.58 Million | -5.74 Million | 50.18 Million | 12.87 Million |
| Investing Cash Flow | -578.99 Million | -669.52 Million | -919.59 Million | -307.17 Million | -117.68 Million | 408.45 Million |
| Investments in PPE | -334.45 Million | -605.78 Million | -561.23 Million | -314.15 Million | -105.21 Million | -256.76 Million |
| Acquisitions | 54.77 Thousand | 250 Thousand | -46.27 Million | -5.33 Million | 105.43 Million | -3.59 Million |
| Investment purchases | -855.6 Million | -1.1 Billion | -1.32 Billion | -1.88 Billion | -2.16 Billion | -1.02 Billion |
| Sales/Maturities of investments | 612.61 Million | 1.03 Billion | 1.01 Billion | 1.89 Billion | 2.15 Billion | 1.69 Billion |
| Other Investing Activities | -1.6 Million | 0.05 | 59.16 Thousand | 33 Thousand | -105.21 Million | 11.56 Thousand |
| Financing Cash Flow | 99.76 Million | -138.9 Million | 555.8 Million | 16.78 Million | -209.37 Million | 19.87 Million |
| Debt repayment | -881.12 Thousand | -1.3 Billion | -290 Million | -220.56 Million | -329.34 Million | -112.04 Million |
| Dividends payments | -56.63 Million | -56.59 Million | -39.26 Million | -31.41 Million | -32.18 Million | -41.38 Million |
| Common Stock Repurchased | -306.18 Thousand | -41.65 Million | -123.26 Million | -36.52 Million | - | - |
| Common Stock Issuance | - | 41.65 Million | 123.26 Million | 36.52 Million | - | - |
| Other Financing Activities | 166.67 Million | 1.22 Billion | 885.41 Million | 274.18 Million | 155.86 Million | 173.3 Million |
| Accounts receivables | -12.59 Million | -187.22 Million | 27.81 Million | 6.96 Million | -12.43 Million | -123.42 Million |
| Accounts payables | 244.94 Million | 295.04 Million | -27.81 Million | 34.19 Million | 71.56 Million | 52.99 Million |
| Inventory | -168.41 Million | -63.05 Million | -2.66 Million | -28.41 Million | -3.53 Million | 55.5 Million |
| Other working capital | -10.78 Million | -20.24 Million | 48.3 Million | 3.9 Million | -5.61 Million | -73.52 Million |
| Cash at beginning of period | 431.08 Million | 763.87 Million | 690.03 Million | 705.2 Million | 751.6 Million | 84.67 Million |
| Cash at end of period | 407.51 Million | 431.08 Million | 763.87 Million | 690.03 Million | 705.2 Million | 751.6 Million |
| Capital Expenditure | -334.45 Million | -605.78 Million | -561.23 Million | -314.15 Million | -105.21 Million | -256.76 Million |
| Effect of forex changes on cash | -2.39 Million | 104.51 Thousand | -474.52 Thousand | - | 11.27 Thousand | -590.17 |
| Net cash flow / Change in cash | -23.56 Million | -332.79 Million | 73.84 Million | -15.17 Million | -46.39 Million | 666.92 Million |
| Free Cash Flow | 123.59 Million | -130.24 Million | -123.13 Million | -38.93 Million | 175.43 Million | -18.16 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -292.99 Million | -54.05 Million | 100.51 Million | 151.79 Million | -97.33 Million | 77.01 Million |
| Depreciation & Amortization | - | 54.08 Million | 54.08 Million | 182.2 Million | 178.57 Million | -78.88 Million |
| Deferred income taxes | - | - | - | -16.09 Million | - | - |
| Stock-based compensation | - | - | - | -10.78 Million | -10.78 Million | - |
| Change in working capital | - | 131.13 Million | - | 47.83 Million | -191.79 Million | -56.21 Million |
| Other non-cash items | -103.94 Million | 244.3 Million | -46.29 Million | 57.96 Million | 322.54 Million | 105.82 Million |
| Investing Cash Flow | 119.99 Million | -23.13 Million | -454.62 Million | -578.99 Million | -14.33 Million | -217.75 Million |
| Investments in PPE | -81.12 Million | -93.61 Million | -96.9 Million | -334.45 Million | -132.53 Million | -60.03 Million |
| Acquisitions | 33.97 Thousand | 10.26 Thousand | - | 54.77 Thousand | -247.54 Thousand | 0.35 |
| Investment purchases | -253.63 Million | -896.2 Million | -545.94 Million | -855.6 Million | 28.81 Million | -170.19 Million |
| Sales/Maturities of investments | 454.71 Million | 966.66 Million | 188.21 Million | 612.61 Million | 90.55 Million | 12.6 Million |
| Other Investing Activities | - | 71.66 Million | -357.72 Million | -1.6 Million | -924.01 Thousand | -129 Thousand |
| Financing Cash Flow | 623.41 Million | -220.87 Million | 362.58 Million | 99.76 Million | -124.15 Million | 131.36 Million |
| Debt repayment | -450 Million | -100 Million | -370 Million | -881.12 Thousand | -300.88 Million | -150 Million |
| Dividends payments | -94.29 Million | -94.29 Million | -1.68 Million | -56.63 Million | -1.63 Million | -1.71 Million |
| Common Stock Repurchased | 22.38 Million | -22.38 Million | - | -306.18 Thousand | -306.18 Thousand | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 56.74 Million | -192.23 Million | -5.73 Million | 166.67 Million | 178.36 Million | 283.07 Million |
| Accounts receivables | - | 140.61 Million | - | -12.59 Million | -12.59 Million | -151.7 Million |
| Accounts payables | - | - | - | 244.94 Million | - | - |
| Inventory | - | -9.48 Million | - | -168.41 Million | -168.41 Million | 95.49 Million |
| Other working capital | - | - | - | -10.78 Million | -10.78 Million | - |
| Cash at beginning of period | 442.31 Million | 577.51 Million | 406.91 Million | 431.08 Million | 561.7 Million | 386.41 Million |
| Cash at end of period | 658.03 Million | 442.31 Million | 369.08 Million | 407.51 Million | 407.51 Million | 561.7 Million |
| Capital Expenditure | -81.12 Million | -93.61 Million | -96.9 Million | -334.45 Million | -132.53 Million | -60.03 Million |
| Effect of forex changes on cash | - | 386.29 Thousand | - | -2.39 Million | -2.39 Million | 213.94 Million |
| Net cash flow / Change in cash | 215.72 Million | -135.2 Million | -37.82 Million | -23.56 Million | -154.19 Million | 175.29 Million |
| Free Cash Flow | -478.06 Million | 42.55 Million | -42.68 Million | 123.59 Million | 68.66 Million | -12.29 Million |
CFRESH
FARYF
AS
EPE
BCTCF
MODRNSH